PharVision Advisers’s United Bankshares UBSI Stock Holding History

PharVision Advisers’s Portfolio UBSI Stock Details UBSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6,085	Closed	-$211K	–	434
2025 Q1	$211K	Buy	+6,085	New	+$223K	0.29%	188

Other funds holding UBSI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PharVision Advisers's UBSI Position: Q2 2025 in Review

PharVision Advisers sold out of United Bankshares (UBSI) in Q2 2025, closing a stake of 6,085 shares — an estimated $211K sold.

PharVision Advisers first reported a position in UBSI in Q1 2025 and held it in 1 quarter. The position peaked at $211K in Q1 2025. 364 funds tracked by Wall St. Rank hold UBSI as of Q2 2025.

PharVision Advisers reported no remaining United Bankshares position as of Q2 2025 after selling out during the quarter.
PharVision Advisers sold 6,085 United Bankshares shares in Q2 2025, an estimated $211K.
PharVision Advisers first reported a position in United Bankshares in Q1 2025 and held it in 1 quarter.
PharVision Advisers's United Bankshares position peaked at $211K in Q1 2025.
364 funds tracked by Wall St. Rank held United Bankshares as of Q2 2025.

Based on PharVision Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.